Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma.

Abstract

Forty patients with AIDS-associated Kaposi's sarcoma (KS) treated with the combination of interferon alpha-2b (IFN-alpha) 10-20 MU day-1 and zidovudine (ZDV), 500-800 mg day-1, were evaluated for safety and efficacy. Eighteen patients (45%) had an overall response (CR+PR) at 3 months and a response persisting for a median of 14 (3-27) months. Patients with… (More)

Topics

Cite this paper

@article{Podzamczer1993LowdoseIA, title={Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma.}, author={Daniel Podzamczer and Ferr{\'a}n Bolao and Bonaventura Clotet and P Garc{\'i}a and Aurora Casanova and X. Pagerols and Francisco Gudiol}, journal={Journal of internal medicine}, year={1993}, volume={233 3}, pages={247-53} }